Status:

COMPLETED

Comparison of Diltiazem and Metoprolol in the Management of Acute Atrial Fibrillation or Atrial Flutter

Lead Sponsor:

Antonios Likourezos

Conditions:

Heart Rate and Rhythm Disorders

Eligibility:

All Genders

18+ years

Phase:

PHASE4

Brief Summary

Acute atrial fibrillation is the most common sustained, clinically significant dysrhythmia encountered in the emergency department (ED) and the most common dysrhythmia treated by emergency physicians....

Detailed Description

We conducted a prospective, randomized, double-blind study to compare the effectiveness of intravenous metoprolol with that of diltiazem in achieving rate control in adult ED patients with rapid atria...

Eligibility Criteria

Inclusion

  • Eligible patients had to have a 12-lead electrocardiogram (ECG) showing atrial fibrillation or atrial flutter with a ventricular rate of greater than or equal to 120 beats per minute and a systolic blood pressure of greater than or equal to 90 mmHg.

Exclusion

  • Patients were excluded if they had any of the following:
  • a systolic blood pressure \<90 mmHg, ventricular rate greater than or equal to 220 beats per minute,
  • QRS \>0.100 seconds, 2nd or 3rd degree atrioventricular (AV) block,
  • temperature \>38.0 ˚C,
  • acute ST elevation myocardial infarction,
  • known history of New York Heart Association Class IV heart failure or
  • active wheezing with a history of bronchial asthma or COPD.
  • In addition, patients were excluded if there was:
  • prehospital administration of diltiazem or any other AV nodal blockading agent,
  • a history of cocaine or methamphetamine use in the previous 24 hours prior to arrival,
  • a history of allergic reaction to diltiazem or metoprolol,
  • a history of sick sinus or pre-excitation syndromes,
  • a history of anemia with hemoglobin \<11.0 g/dl,
  • pregnancy or breastfeeding.

Key Trial Info

Start Date :

June 1 2009

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

November 1 2010

Estimated Enrollment :

54 Patients enrolled

Trial Details

Trial ID

NCT01914926

Start Date

June 1 2009

End Date

November 1 2010

Last Update

May 15 2014

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Maimonides Medical Center

Brooklyn, New York, United States, 11219